Showing results (101-110 of 307) with videos related to

Sort By:
Pageof 31
Clinical Parkinsonism & Related Disorders|August 13, 2025
How to dose extended-release carbidopa-levodopa capsules (IPX203, CREXONT®) in patients with Parkinson's diseaseRobert A Hauser, Yasar Torres-Yaghi, Stanley Fisher, et al.
The International Journal of Neuroscience|March 19, 2016
Efficacy of rasagiline in early Parkinson's disease: a meta-analysis of data from the TEMPO and ADAGIO studiesRobert A Hauser, Victor Abler, Eli Eyal, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 7, 2006
Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's diseaseRobert A Hauser, Laurence Salin, Nolwenn Juhel, et al.
Parkinsonism & Related Disorders|November 19, 2010
Tolerability and efficacy of switching from oral selegiline to Zydis selegiline in patients with Parkinson's diseaseWilliam G Ondo, Christine Hunter, Stuart H Isaacson, et al.
NPJ Parkinson'S Disease|March 19, 2022
Amantadine delayed release/extended release capsules significantly reduce OFF time in Parkinson's diseaseRobert A Hauser, Judy Lytle, Andrea E Formella, et al.
Current Treatment Options in Neurology|March 12, 2003
Autonomic Nervous System Dysfunction in Parkinson's DiseaseTheresa A. Zesiewicz, Matthew J. Baker, Mervat Wahba, et al.
Expert Opinion on Pharmacotherapy|August 28, 2004
Botulinum toxin A for the treatment of cervical dystoniaTheresa A Zesiewicz, William Stamey, Kelly L Sullivan, et al.
Parkinsonism & Related Disorders|December 22, 2020
The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenantPeter A LeWitt, Stephen D Aradi, Robert A Hauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuationsBonnie P Hersh, Nancy L Earl, Robert A Hauser, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 13, 2014
Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's diseaseRobert A Hauser, Dee Silver, Azhar Choudhry, et al.
Pageof 31